EUVIMEDEUVIMED entdecken
Crossref

Self‐Assembled Carrier‐Free Nanomedicines Potentiate Chemo‐Photothermal Immunotherapy by Overcoming Prostaglandin E2‐Mediated Immunosuppression

Xiaoliang Deng, Lina Wu, Boxin Chen, Xiaohui Tang, Shiying Xu, Yinxing Huang, Fan Pan, Jun Lu, Xianquan Feng iD

Small · 2026-04 · 22 (20)

DOI: 10.1002/smll.202512540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 10.02.2026. Verfasst von Xiaoliang Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Transplant Biology of Laboratory of Basic Medicine, Fuzong Teaching Hospital of Fujian University of Traditional …. Hauptthemen laut MEDLINE: Dinoprostone, Immunotherapy, Nanomedicine, Photothermal Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Joint Funds for the Innovation of Science and Technology of Fujian Province, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation plays a pivotal role in fostering an immunosuppressive tumor microenvironment, which diminishes tumor immunogenic cell death (ICD) and subsequently promotes tumor recurrence and metastasis. The COX‐2/PGE2 signaling axis has been identified as a crucial regulator in the establishment of immunosuppressive conditions. Herein, this work developed an excipient‐free nanomedicine (IPC NPs) via non‐covalent self‐assembly, integrating indocyanine green and paclitaxel (dual ICD inducers) with celecoxib (COX‐2/PGE2 inhibitor) for combined chemo‐photothermal therapy with anti‐inflammatory effects. The IPC NPs displayed monodisperse characteristics with optimal near‐infrared responsiveness, significantly enhancing tumor tissue permeation while demonstrating synergistic chemo‐photothermal cytotoxicity against triple‐negative breast cancer (TNBC). Notably, IPC NPs‐encapsulated celecoxib effectively remodeled the tumor inflammatory microenvironment by attenuating therapy‐induced inflammatory responses, thereby potentiating ICD. This triple therapy regimen promoted dendritic cell maturation, enhanced cytotoxic T lymphocyte infiltration into tumor tissues, and upregulated effector memory T cell populations in TNBC. These immunomodulatory effects substantially ameliorated the immunosuppressive tumor microenvironment, leading to significant inhibition of primary tumor growth and metastasis. Collectively, this work presents a novel carrier‐free nanotherapeutic strategy that synergistically combines chemo‐photothermal‐inflammatory suppression therapy, offering a promising approach for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DinoprostoneImmunotherapyNanomedicinePhotothermal TherapyImmunosuppression TherapyAnimalsFemaleHumansCell Line, TumorPaclitaxelTumor MicroenvironmentCelecoxibIndocyanine GreenMiceDendritic CellsTriple Negative Breast Neoplasms

Stichwörter der Autor:innen

celecoxibimmunogenic cell deathindocyanine greenpaclitaxeltriple‐negative breast cancer

Substanzen

DinoprostonePaclitaxelCelecoxibIndocyanine Green

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Transplant Biology of Laboratory of Basic Medicine, Fuzong Teaching Hospital of Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China.
  • School of Biomedical Science, Huaqiao University, Quanzhou, China.
  • School of Pharmacy, Fujian Medical University, Fuzhou, China.
  • School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • 900th Hospital of PLA Joint Logistic Support Force, Fuzong Clinical College of Fujian Medical University, Fuzhou, China.

ORCID-Profile: Xianquan Feng

Förderung

  • National Natural Science Foundation of China
  • Joint Funds for the Innovation of Science and Technology of Fujian Province
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Deng, X., Wu, L., Chen, B., Tang, X., Xu, S., Huang, Y., Pan, F., Lu, J., & Feng, X. (2026). Self‐Assembled Carrier‐Free Nanomedicines Potentiate Chemo‐Photothermal Immunotherapy by Overcoming Prostaglandin E2‐Mediated Immunosuppression. Small, 22(20). https://doi.org/10.1002/smll.202512540

Vancouver

Deng X, Wu L, Chen B, Tang X, Xu S, Huang Y, et al. Self‐Assembled Carrier‐Free Nanomedicines Potentiate Chemo‐Photothermal Immunotherapy by Overcoming Prostaglandin E2‐Mediated Immunosuppression. Small. 2026;22(20). doi:10.1002/smll.202512540

BibTeX
@article{Deng2026,
  author = {Deng, Xiaoliang and Wu, Lina and Chen, Boxin and Tang, Xiaohui and Xu, Shiying and Huang, Yinxing and Pan, Fan and Lu, Jun and Feng, Xianquan},
  title = {Self‐Assembled Carrier‐Free Nanomedicines Potentiate Chemo‐Photothermal Immunotherapy by Overcoming Prostaglandin E2‐Mediated Immunosuppression},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {20},
  doi = {10.1002/smll.202512540}
}
Kostenlos starten →